Zyprexa News
Most Popular Zyprexa Story
Lilly's losses put pressure on key Alzheimer's program
Eli Lilly ($LLY) saw its fourth-quarter profit slide 27% after the loss of its patent on Zyprexa last year hit sales of the schizophrenia drug harder than expected, Bloomberg reported. And the fresh Read more...
Latest Headlines
- January 31, 2012
- November 22, 2011
- February 7, 2011
- March 31, 2008
- October 17, 2007
- January 4, 2007
- December 20, 2006
- December 17, 2006
- December 17, 2006
- November 30, 2006
- October 11, 2006
- September 19, 2005
- June 9, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
